Dr. Joe Jankowski

Dr. Jankowski is a nationally recognized healthcare commercialization leader, specializing in early-stage opportunity assessment, commercial licensing and corporate financing and collaboration structuring.  Since 2003, Jankowski has served as a contributor to and leader of Case Western Reserve University innovation; for nearly a decade, he led the University’s technology transfer office and in 2013 was appointed as CWRU’s first Chief Innovation Officer.  In 2018, he co-founded the Pathway in Health Entrepreneurship and Innovation, at the Case School of Medicine, to prepare MD students for career-long innovative contributions.  Jankowski continues to lead the Pathway and additionally serves as the instructor for two required courses in the CWRU Masters of Regenerative Medicine Entrepreneurship program.  Jankowski is active in corporate-level governance, having served as a founding or current board member and trustee for a myriad of economic development and entrepreneurial enterprises, including Arteriocyte, Cleveland Water Alliance, Neuros Medical, and RoadPrintz.  

Jankowski is an active contributor to healthcare innovation, serving as a retained advisor to Baptist Health South Florida Innovations, Henry Ford Health Innovations, and Tampa General Hospital Ventures.  He was a member of the inaugural Cleveland Clinic Innovations program, which he joined following a role as a technology analyst at Battelle Memorial Institute.  He is a founding and current member of the Case Coulter Translational Partnership oversight committee and a regular reviewer for the federal SBIR and Congressionally Directed Medical Research Programs and the Michigan Translational Research and Commercialization for Life Sciences Innovation Hub.

Jankowski holds a Ph.D. in Chemistry from SUNY ESF, an MBA from the Weatherhead School of Management, and dual bachelor’s degrees in Chemical Process and Environmental Engineering Technologies from the University of Dayton.

‍